Logo image of BE

BLOOM ENERGY CORP- A (BE) Stock Fundamental Analysis

NYSE:BE - New York Stock Exchange, Inc. - US0937121079 - Common Stock - Currency: USD

16.24  -0.76 (-4.47%)

Fundamental Rating

5

BE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 97 industry peers in the Electrical Equipment industry. BE has an average financial health and profitability rating. BE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BE had positive earnings in the past year.
BE had a positive operating cash flow in the past year.
In the past 5 years BE always reported negative net income.
In the past 5 years BE reported 4 times negative operating cash flow.
BE Yearly Net Income VS EBIT VS OCF VS FCFBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.10%, BE is in the better half of the industry, outperforming 64.95% of the companies in the same industry.
BE has a Return On Equity of -5.20%. This is in the better half of the industry: BE outperforms 64.95% of its industry peers.
BE's Return On Invested Capital of 0.90% is fine compared to the rest of the industry. BE outperforms 64.95% of its industry peers.
Industry RankSector Rank
ROA -1.1%
ROE -5.2%
ROIC 0.9%
ROA(3y)-9.7%
ROA(5y)-9.89%
ROE(3y)-51.27%
ROE(5y)-90.79%
ROIC(3y)N/A
ROIC(5y)N/A
BE Yearly ROA, ROE, ROICBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

BE has a Operating Margin of 1.55%. This is in the better half of the industry: BE outperforms 65.98% of its industry peers.
BE's Gross Margin of 27.46% is fine compared to the rest of the industry. BE outperforms 62.89% of its industry peers.
In the last couple of years the Gross Margin of BE has grown nicely.
Industry RankSector Rank
OM 1.55%
PM (TTM) N/A
GM 27.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.54%
GM growth 5Y17.17%
BE Yearly Profit, Operating, Gross MarginsBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BE is destroying value.
BE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BE has more shares outstanding
Compared to 1 year ago, BE has an improved debt to assets ratio.
BE Yearly Shares OutstandingBE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BE Yearly Total Debt VS Total AssetsBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.29, we must say that BE is in the distress zone and has some risk of bankruptcy.
BE has a Altman-Z score (0.29) which is comparable to the rest of the industry.
BE has a debt to FCF ratio of 41.88. This is a negative value and a sign of low solvency as BE would need 41.88 years to pay back of all of its debts.
BE has a Debt to FCF ratio of 41.88. This is in the better half of the industry: BE outperforms 63.92% of its industry peers.
A Debt/Equity ratio of 2.24 is on the high side and indicates that BE has dependencies on debt financing.
The Debt to Equity ratio of BE (2.24) is worse than 75.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.24
Debt/FCF 41.88
Altman-Z 0.29
ROIC/WACC0.12
WACC7.53%
BE Yearly LT Debt VS Equity VS FCFBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

BE has a Current Ratio of 3.21. This indicates that BE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.21, BE is in the better half of the industry, outperforming 79.38% of the companies in the same industry.
BE has a Quick Ratio of 2.35. This indicates that BE is financially healthy and has no problem in meeting its short term obligations.
BE's Quick ratio of 2.35 is amongst the best of the industry. BE outperforms 82.47% of its industry peers.
Industry RankSector Rank
Current Ratio 3.21
Quick Ratio 2.35
BE Yearly Current Assets VS Current LiabilitesBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 211.76% over the past year.
Looking at the last year, BE shows a quite strong growth in Revenue. The Revenue has grown by 10.52% in the last year.
BE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.42% yearly.
EPS 1Y (TTM)211.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%514.29%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y14.88%
Revenue growth 5Y13.42%
Sales Q2Q%60.37%

3.2 Future

BE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.80% yearly.
The Revenue is expected to grow by 16.19% on average over the next years. This is quite good.
EPS Next Y115.13%
EPS Next 2Y111.35%
EPS Next 3Y92.4%
EPS Next 5Y39.8%
Revenue Next Year22.76%
Revenue Next 2Y21.91%
Revenue Next 3Y21.31%
Revenue Next 5Y16.19%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BE Yearly Revenue VS EstimatesBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
BE Yearly EPS VS EstimatesBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 85.47, which means the current valuation is very expensive for BE.
68.04% of the companies in the same industry are more expensive than BE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of BE to the average of the S&P500 Index (28.29), we can say BE is valued expensively.
With a Price/Forward Earnings ratio of 39.73, BE can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, BE is valued a bit cheaper than the industry average as 68.04% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BE to the average of the S&P500 Index (21.32), we can say BE is valued expensively.
Industry RankSector Rank
PE 85.47
Fwd PE 39.73
BE Price Earnings VS Forward Price EarningsBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

63.92% of the companies in the same industry are more expensive than BE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BE is valued a bit cheaper than 63.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 112.94
EV/EBITDA 59.29
BE Per share dataBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

BE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BE's earnings are expected to grow with 92.40% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y111.35%
EPS Next 3Y92.4%

0

5. Dividend

5.1 Amount

BE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLOOM ENERGY CORP- A

NYSE:BE (4/21/2025, 11:32:09 AM)

16.24

-0.76 (-4.47%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners85.53%
Inst Owner Change-0.14%
Ins Owners3.02%
Ins Owner Change4.13%
Market Cap3.74B
Analysts73.33
Price Target27.81 (71.24%)
Short Float %23.29%
Short Ratio6.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)N/A
DP-5.02%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-36.19%
Min EPS beat(2)-111.83%
Max EPS beat(2)39.45%
EPS beat(4)1
Avg EPS beat(4)-39.18%
Min EPS beat(4)-111.83%
Max EPS beat(4)39.45%
EPS beat(8)2
Avg EPS beat(8)27.59%
EPS beat(12)3
Avg EPS beat(12)-8.93%
EPS beat(16)4
Avg EPS beat(16)-35.07%
Revenue beat(2)1
Avg Revenue beat(2)-3.93%
Min Revenue beat(2)-16.08%
Max Revenue beat(2)8.23%
Revenue beat(4)2
Avg Revenue beat(4)-2.63%
Min Revenue beat(4)-16.08%
Max Revenue beat(4)8.23%
Revenue beat(8)4
Avg Revenue beat(8)-4.59%
Revenue beat(12)7
Avg Revenue beat(12)-2.34%
Revenue beat(16)8
Avg Revenue beat(16)-3.22%
PT rev (1m)8.58%
PT rev (3m)21%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-95.56%
EPS NY rev (1m)0.61%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-6.32%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)2.94%
Valuation
Industry RankSector Rank
PE 85.47
Fwd PE 39.73
P/S 2.54
P/FCF 112.94
P/OCF 40.69
P/B 6.66
P/tB 6.66
EV/EBITDA 59.29
EPS(TTM)0.19
EY1.17%
EPS(NY)0.41
Fwd EY2.52%
FCF(TTM)0.14
FCFY0.89%
OCF(TTM)0.4
OCFY2.46%
SpS6.39
BVpS2.44
TBVpS2.44
PEG (NY)0.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -5.2%
ROCE 1.13%
ROIC 0.9%
ROICexc 1.49%
ROICexgc 1.49%
OM 1.55%
PM (TTM) N/A
GM 27.46%
FCFM 2.25%
ROA(3y)-9.7%
ROA(5y)-9.89%
ROE(3y)-51.27%
ROE(5y)-90.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.54%
GM growth 5Y17.17%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 2.24
Debt/FCF 41.88
Debt/EBITDA 16.6
Cap/Depr 110.94%
Cap/Sales 3.99%
Interest Coverage 0.41
Cash Conversion 121.12%
Profit Quality N/A
Current Ratio 3.21
Quick Ratio 2.35
Altman-Z 0.29
F-Score6
WACC7.53%
ROIC/WACC0.12
Cap/Depr(3y)144.77%
Cap/Depr(5y)119.97%
Cap/Sales(3y)6.67%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)211.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%514.29%
EPS Next Y115.13%
EPS Next 2Y111.35%
EPS Next 3Y92.4%
EPS Next 5Y39.8%
Revenue 1Y (TTM)10.52%
Revenue growth 3Y14.88%
Revenue growth 5Y13.42%
Sales Q2Q%60.37%
Revenue Next Year22.76%
Revenue Next 2Y21.91%
Revenue Next 3Y21.31%
Revenue Next 5Y16.19%
EBIT growth 1Y111.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.67%
EBIT Next 3Y114.15%
EBIT Next 5Y64.62%
FCF growth 1Y107.27%
FCF growth 3YN/A
FCF growth 5Y-21.71%
OCF growth 1Y124.7%
OCF growth 3YN/A
OCF growth 5Y-10.9%